GlaxoSmithKline Fined $750 Million for Tainted Drugs
GlaxoSmithKline PLC agreed to pay $750 million on Tuesday to settle a U.S. government false-claims lawsuit.

The drugs in question include the antidepressant Paxil CR, anti-nausea medication Kytril, Bactroban ointment, and diabetes drug Avandamet. Glaxosmithkline/AFP/Getty Images
|Updated:





